Tachykinin receptor-selectivity of the potential glioblastoma-targeted therapy, DOTA-[Thi8,Met(O2)11]-substance P
Loading...
Date
Authors
Suthiram, Janine
Pieters, Ane
Moosa, Zulfiah Mohamed
Zeevaart, Jan Rijn
Sathekge, Mike Machaba
Ebenhan, Thomas
Anderson, Ross Calley
Newton, Claire L.
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Abstract
Please read abstract in article.
Description
The data presented in this study are available on request from the corresponding author (C.L.N.).
Keywords
Neurokinin-1 receptor, Neurokinin-2 receptor, Neurokinin-3 receptor, Mas-related G protein-coupled receptor subtype 2, Receptor selectivity, Theranostics, Glioblastoma multiforme, SDG-03: Good health and well-being
Sustainable Development Goals
SDG-03:Good heatlh and well-being
SDG-09: Industry, innovation and infrastructure
SDG-09: Industry, innovation and infrastructure
Citation
J.; Pieters, A.; Mohamed Moosa, Z.; Zeevaart, J.R.; Sathekge, M.M.; Ebenhan, T.; Anderson, R.C.; Newton, C.L. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi8,Met(O2)11]-Substance P. International Journal of Molecular Sciences 2023, 24, 2134. https://doi.org/10.3390/ijms24032134.